Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.

Genomic technologies including microarrays and next-generation sequencing have enabled the generation of molecular signatures of prostate cancer. Lists of differentially expressed genes between malignant and non-malignant states are thought to be fertile sources of putative prostate cancer biomarker...

Full description

Bibliographic Details
Main Authors: Jennifer S Myers, Ariana K von Lersner, Charles J Robbins, Qing-Xiang Amy Sang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4687717?pdf=render
_version_ 1828795128208162816
author Jennifer S Myers
Ariana K von Lersner
Charles J Robbins
Qing-Xiang Amy Sang
author_facet Jennifer S Myers
Ariana K von Lersner
Charles J Robbins
Qing-Xiang Amy Sang
author_sort Jennifer S Myers
collection DOAJ
description Genomic technologies including microarrays and next-generation sequencing have enabled the generation of molecular signatures of prostate cancer. Lists of differentially expressed genes between malignant and non-malignant states are thought to be fertile sources of putative prostate cancer biomarkers. However such lists of differentially expressed genes can be highly variable for multiple reasons. As such, looking at differential expression in the context of gene sets and pathways has been more robust. Using next-generation genome sequencing data from The Cancer Genome Atlas, differential gene expression between age- and stage- matched human prostate tumors and non-malignant samples was assessed and used to craft a pathway signature of prostate cancer. Up- and down-regulated genes were assigned to pathways composed of curated groups of related genes from multiple databases. The significance of these pathways was then evaluated according to the number of differentially expressed genes found in the pathway and their position within the pathway using Gene Set Enrichment Analysis and Signaling Pathway Impact Analysis. The "transforming growth factor-beta signaling" and "Ran regulation of mitotic spindle formation" pathways were strongly associated with prostate cancer. Several other significant pathways confirm reported findings from microarray data that suggest actin cytoskeleton regulation, cell cycle, mitogen-activated protein kinase signaling, and calcium signaling are also altered in prostate cancer. Thus we have demonstrated feasibility of pathway analysis and identified an underexplored area (Ran) for investigation in prostate cancer pathogenesis.
first_indexed 2024-12-12T03:59:01Z
format Article
id doaj.art-a85250602dbf40cbb202f212346abafa
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T03:59:01Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a85250602dbf40cbb202f212346abafa2022-12-22T00:39:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014532210.1371/journal.pone.0145322Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Jennifer S MyersAriana K von LersnerCharles J RobbinsQing-Xiang Amy SangGenomic technologies including microarrays and next-generation sequencing have enabled the generation of molecular signatures of prostate cancer. Lists of differentially expressed genes between malignant and non-malignant states are thought to be fertile sources of putative prostate cancer biomarkers. However such lists of differentially expressed genes can be highly variable for multiple reasons. As such, looking at differential expression in the context of gene sets and pathways has been more robust. Using next-generation genome sequencing data from The Cancer Genome Atlas, differential gene expression between age- and stage- matched human prostate tumors and non-malignant samples was assessed and used to craft a pathway signature of prostate cancer. Up- and down-regulated genes were assigned to pathways composed of curated groups of related genes from multiple databases. The significance of these pathways was then evaluated according to the number of differentially expressed genes found in the pathway and their position within the pathway using Gene Set Enrichment Analysis and Signaling Pathway Impact Analysis. The "transforming growth factor-beta signaling" and "Ran regulation of mitotic spindle formation" pathways were strongly associated with prostate cancer. Several other significant pathways confirm reported findings from microarray data that suggest actin cytoskeleton regulation, cell cycle, mitogen-activated protein kinase signaling, and calcium signaling are also altered in prostate cancer. Thus we have demonstrated feasibility of pathway analysis and identified an underexplored area (Ran) for investigation in prostate cancer pathogenesis.http://europepmc.org/articles/PMC4687717?pdf=render
spellingShingle Jennifer S Myers
Ariana K von Lersner
Charles J Robbins
Qing-Xiang Amy Sang
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
PLoS ONE
title Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
title_full Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
title_fullStr Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
title_full_unstemmed Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
title_short Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
title_sort differentially expressed genes and signature pathways of human prostate cancer
url http://europepmc.org/articles/PMC4687717?pdf=render
work_keys_str_mv AT jennifersmyers differentiallyexpressedgenesandsignaturepathwaysofhumanprostatecancer
AT arianakvonlersner differentiallyexpressedgenesandsignaturepathwaysofhumanprostatecancer
AT charlesjrobbins differentiallyexpressedgenesandsignaturepathwaysofhumanprostatecancer
AT qingxiangamysang differentiallyexpressedgenesandsignaturepathwaysofhumanprostatecancer